Molecular basis of MAP kinase regulation

Mitogen‐activated protein kinases (MAPKs; ERK1/2, p38, JNK, and ERK5) have evolved to transduce environmental and developmental signals (growth factors, stress) into adaptive and programmed responses (differentiation, inflammation, apoptosis). Almost 20 years ago, it was discovered that MAPKs contain a docking site in the C‐terminal lobe that binds a conserved 13‐16 amino acid sequence known as the D‐ or KIM‐motif (kinase interaction motif). Recent crystal structures of MAPK:KIM‐peptide complexes are leading to a precise understanding of how KIM sequences contribute to MAPK selectivity. In addition, new crystal and especially NMR studies are revealing how residues outside the canonical KIM motif interact with specific MAPKs and contribute further to MAPK selectivity and signaling pathway fidelity. In this review, we focus on these recent studies, with an emphasis on the use of NMR spectroscopy, isothermal titration calorimetry and small angle X‐ray scattering to investigate these processes.

[1]  W. Peti,et al.  Sequence-specific backbone 1H, 13C and 15N assignments of the 34 kDa catalytic domain of PTPN5 (STEP) , 2014, Biomolecular NMR assignments.

[2]  W. Peti,et al.  The differential regulation of p38α by the neuronal kinase interaction motif protein tyrosine phosphatases, a detailed molecular study. , 2013, Structure.

[3]  W. Peti,et al.  Structural Basis for the Regulation of the Mitogen-activated Protein (MAP) Kinase p38α by the Dual Specificity Phosphatase 16 MAP Kinase Binding Domain in Solution*♦ , 2013, The Journal of Biological Chemistry.

[4]  Jiawei Wu,et al.  Crystal structure of the p38α MAP kinase in complex with a docking peptide from TAB1 , 2013, Science China Life Sciences.

[5]  E. Pasquale,et al.  Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK , 2013, Nature Communications.

[6]  Charles R Sanders,et al.  The quiet renaissance of protein nuclear magnetic resonance. , 2013, Biochemistry.

[7]  A. Reményi,et al.  Protein–peptide complex crystallization: a case study on the ERK2 mitogen-activated protein kinase , 2013, Acta crystallographica. Section D, Biological crystallography.

[8]  A. Reményi,et al.  Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module , 2013, The Journal of Biological Chemistry.

[9]  G. Hummer,et al.  The Molecular Mechanism of Substrate Engagement and Immunosuppressant Inhibition of Calcineurin , 2013, PLoS biology.

[10]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases (MKPs) , 2013, The FEBS journal.

[11]  D. Morrison,et al.  A CC-SAM, for Coiled Coil–Sterile α Motif, Domain Targets the Scaffold KSR-1 to Specific Sites in the Plasma Membrane , 2012, Science Signaling.

[12]  Jerome C Nwachukwu,et al.  Structural mechanisms of allostery and autoinhibition in JNK family kinases. , 2012, Structure.

[13]  K. Dalby,et al.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α. , 2012, Biochemistry.

[14]  M. Bollen,et al.  The molecular basis for substrate specificity of the nuclear NIPP1:PP1 holoenzyme. , 2012, Structure.

[15]  Hagen Blankenburg,et al.  Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking Groove , 2012, Science Signaling.

[16]  T. Tan,et al.  DUSPs, to MAP kinases and beyond , 2012, Cell & Bioscience.

[17]  K. Dalby,et al.  Assignment of backbone resonances in a eukaryotic protein kinase - ERK2 as a representative example. , 2012, Methods in molecular biology.

[18]  Zhi-Xin Wang,et al.  A Distinct Interaction Mode Revealed by the Crystal Structure of the Kinase p38α with the MAPK Binding Domain of the Phosphatase MKP5 , 2011, Science Signaling.

[19]  Gerhard Hummer,et al.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase. , 2011, Nature chemical biology.

[20]  H. Schwalbe,et al.  NMR Spectroscopic Investigations of the Activated p38α Mitogen‐Activated Protein Kinase , 2011, ChemBioChem.

[21]  Gerhard Hummer,et al.  Resting and active states of the ERK2:HePTP complex. , 2011, Journal of the American Chemical Society.

[22]  Pengyu Y. Ren,et al.  Solution NMR insights into docking interactions involving inactive ERK2. , 2011, Biochemistry.

[23]  T. Kaoud,et al.  A Model of a MAPK•Substrate Complex in an Active Conformation: A Computational and Experimental Approach , 2011, PloS one.

[24]  Zhi-Xin Wang,et al.  Mitogen-activated Protein Kinase (MAPK) Phosphatase 3-mediated Cross-talk between MAPKs ERK2 and p38α* , 2011, The Journal of Biological Chemistry.

[25]  G. Hummer,et al.  SAXS ensemble refinement of ESCRT-III CHMP3 conformational transitions. , 2011, Structure.

[26]  E. Goldsmith,et al.  The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution. , 2010, Structure.

[27]  Mingjie Zhang,et al.  Phosphorylation of DCC by ERK2 is facilitated by direct docking of the receptor P1 domain to the kinase. , 2010, Structure.

[28]  A. Cuadrado,et al.  Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.

[29]  Pengyu Y. Ren,et al.  Phosphorylation of the transcription factor Ets-1 by ERK2: rapid dissociation of ADP and phospho-Ets-1. , 2010, Biochemistry.

[30]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[31]  A. Nairn,et al.  Spinophilin directs Protein Phosphatase 1 specificity by blocking substrate binding sites , 2010, Nature Structural &Molecular Biology.

[32]  S. Burchill,et al.  p38(MAPK): stress responses from molecular mechanisms to therapeutics. , 2009, Trends in molecular medicine.

[33]  Deborah K. Morrison,et al.  Signaling dynamics of the KSR1 scaffold complex , 2009, Proceedings of the National Academy of Sciences.

[34]  Lee Bardwell,et al.  Selectivity of Docking Sites in MAPK Kinases* , 2009, Journal of Biological Chemistry.

[35]  D. Sacks,et al.  Protein scaffolds in MAP kinase signalling. , 2009, Cellular signalling.

[36]  K. Patterson,et al.  Dual-specificity phosphatases: critical regulators with diverse cellular targets. , 2009, The Biochemical journal.

[37]  W. Peti,et al.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase. , 2008, Biochemistry.

[38]  A. Barr,et al.  Sequence-specific 1H, 13C and 15N backbone resonance assignments of the 34 kDa catalytic domain of human PTPN7 , 2008, Biomolecular NMR assignments.

[39]  Christian Griesinger,et al.  Dynamics in the p38alpha MAP kinase-SB203580 complex observed by liquid-state NMR spectroscopy. , 2008, Angewandte Chemie.

[40]  Alexandre M J J Bonvin,et al.  HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets , 2007, Proteins.

[41]  J. Thorner,et al.  Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae. , 2007, Biochimica et biophysica acta.

[42]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[43]  L. Tong,et al.  Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5 , 2007, Protein science : a publication of the Protein Society.

[44]  M. Yaffe.  Faculty Opinions recommendation of Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer. , 2007 .

[45]  Bennett T. Farmer,et al.  Molecular basis of MAPK-activated protein kinase 2:p38 assembly , 2007, Proceedings of the National Academy of Sciences.

[46]  C. Lepre,et al.  Crystal Structure of the P38α-MAPKAP Kinase 2 Heterodimer* , 2007, Journal of Biological Chemistry.

[47]  E. Goldsmith,et al.  Docking interactions induce exposure of activation loop in the MAP kinase ERK2. , 2006, Structure.

[48]  Yoshiki Tsuchiya,et al.  Regulatory mechanisms and functions of MAP kinase signaling pathways , 2006, IUBMB life.

[49]  Bo Zhou,et al.  Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Harald Schwalbe,et al.  NMR characterization of kinase p38 dynamics in free and ligand-bound forms. , 2006, Angewandte Chemie.

[51]  K. Dalby,et al.  Quantifying ERK2-protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains. , 2005, Biochimica et biophysica acta.

[52]  Wendell A Lim,et al.  The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. , 2005, Molecular cell.

[53]  K. Saxena,et al.  NMR backbone assignment of the mitogen-activated protein (MAP) kinase p38 , 2005, Journal of biomolecular NMR.

[54]  C. Pargellis,et al.  Catalysis and Function of the p38α·MK2a Signaling Complex , 2004 .

[55]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[56]  Sam-Yong Park,et al.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 , 2004, The EMBO journal.

[57]  E. Goldsmith,et al.  Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. , 2004, Molecular cell.

[58]  C. Pargellis,et al.  Catalysis and function of the p38 alpha.MK2a signaling complex. , 2004, Biochemistry.

[59]  R. Pulido,et al.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. , 2003, The Biochemical journal.

[60]  M. H. Werner,et al.  Recognition of ERK MAP kinase by PEA‐15 reveals a common docking site within the death domain and death effector domain , 2002, The EMBO journal.

[61]  Radha Akella,et al.  Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.

[62]  R. Pulido,et al.  Two Clusters of Residues at the Docking Groove of Mitogen-activated Protein Kinases Differentially Mediate Their Functional Interaction with the Tyrosine Phosphatases PTP-SL and STEP* , 2002, The Journal of Biological Chemistry.

[63]  M. Cobb,et al.  Hydrophobic as Well as Charged Residues in Both MEK1 and ERK2 Are Important for Their Proper Docking* , 2001, The Journal of Biological Chemistry.

[64]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[65]  Ming-Ming Zhou,et al.  Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. , 2001, Molecular cell.

[66]  E. Nishida,et al.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions , 2001, The EMBO journal.

[67]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[68]  Roger J. Davis,et al.  The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins , 1999, Molecular and Cellular Biology.

[69]  Tomas Mustelin,et al.  Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase , 1999, Nature Cell Biology.

[70]  Andrew D. Sharrocks,et al.  Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors , 1999, Molecular and Cellular Biology.

[71]  J. Hahn,et al.  Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. , 1999, Blood.

[72]  T. Mustelin,et al.  Inhibition of T Cell Signaling by Mitogen-activated Protein Kinase-targeted Hematopoietic Tyrosine Phosphatase (HePTP)* , 1999, The Journal of Biological Chemistry.

[73]  T. Sturgill,et al.  Identification of an Extracellular Signal-regulated Kinase (ERK) Docking Site in Ribosomal S6 Kinase, a Sequence Critical for Activation by ERK in Vivo * , 1999, The Journal of Biological Chemistry.

[74]  C. Schutt,et al.  Domain motions in actin. , 1998, Journal of molecular biology.

[75]  E. Goldsmith,et al.  The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  B. Cairns,et al.  Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7 , 1996, Molecular and cellular biology.

[77]  B. Wieringa,et al.  A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain. , 1995, The Biochemical journal.

[78]  I. Tsigelny,et al.  JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. , 1994, Genes & development.

[79]  Elizabeth J. Goldsmith,et al.  Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.

[80]  J. Frost,et al.  Regulation of the MAP kinase cascade. , 1994, Cellular & molecular biology research.

[81]  M. Minden,et al.  Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) , 1992, European journal of immunology.

[82]  P. Lombroso,et al.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Cobb,et al.  Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. , 1991, Cell regulation.

[84]  T. Hunter,et al.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.

[85]  P. Greengard,et al.  Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom. , 1969, Proceedings of the National Academy of Sciences of the United States of America.